LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 89 filers reported holding LEGEND BIOTECH CORP in Q2 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420,800,369 | -2.7% | 6,264,707 | 0.0% | 8.28% | +1.5% |
| Q2 2023 | $432,452,724 | +268.1% | 6,264,707 | +157.1% | 8.16% | +207.1% |
| Q1 2023 | $117,474,673 | -3.4% | 2,436,223 | 0.0% | 2.66% | +7.8% |
| Q4 2022 | $121,616,252 | +27.5% | 2,436,223 | +4.2% | 2.47% | +21.2% |
| Q3 2022 | $95,415,000 | +137.8% | 2,338,610 | +139.2% | 2.04% | +216.1% |
| Q2 2021 | $40,126,000 | -40.8% | 977,503 | -59.4% | 0.64% | -32.1% |
| Q4 2020 | $67,818,000 | -8.8% | 2,408,292 | 0.0% | 0.95% | -30.3% |
| Q3 2020 | $74,344,000 | -29.6% | 2,408,292 | -3.0% | 1.36% | -33.9% |
| Q2 2020 | $105,631,000 | – | 2,481,942 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |